BACKGROUND: Expiratory flow limitation (EFL) by negative expiratory pressure (NEP) testing, quantified as the expiratory flow-limited part of the flow-volume curve, may be influenced by airway obstruction of intrathoracic and extrathoracic origins. NEP application during tidal expiration immediately determines a rise in expiratory flow (V) followed by a short-lasting V drop (deltaV), reflecting upper airway collapsibility. PURPOSES: This study investigated if a new NEP test analysis on the transient expiratory DeltaV after NEP application for detection of upper airway V limitation is able to identify obstructive sleep apnea (OSA) subjects and its severity. METHODS: Thirty-seven male subjects (mean +/- SD age, 46 +/- 11 years; mean body mass index [BMI], 34 +/- 7 kg/m2) with suspected OSA and with normal spirometric values underwent nocturnal polysomnography and diurnal NEP testing at - 5 cm H2O and - 10 cm H2O in sitting and supine positions. RESULTS: deltaV (percentage of the peak V [%Vpeak]) was better correlated to apnea-hypopnea index (AHI) than the EFL measured as V, during NEP application, equal or inferior to the corresponding V during control (EFL), and expressed as percentage of control tidal volume (%Vt). AHI values were always high (> 44 events/h) in subjects with BMI > 35 kg/m2, while they were very scattered (range, 0.5 to 103.5 events/h) in subjects with BMI < 35 kg/m2. In these subjects, AHI still correlated to deltaV (%Vpeak) in both sitting and supine positions at both NEP pressures. CONCLUSIONS: OSA severity is better related to deltaV (%Vpeak) than EFL (%Vt) in subjects referred to sleep centers. DeltaV (%Vpeak) can be a marker of OSA, and it is particularly useful in nonseverely obese subjects.
BACKGROUND: Expiratory flow limitation (EFL) by negative expiratory pressure (NEP) testing, quantified as the expiratory flow-limited part of the flow-volume curve, may be influenced by airway obstruction of intrathoracic and extrathoracic origins. NEP application during tidal expiration immediately determines a rise in expiratory flow (V) followed by a short-lasting V drop (deltaV), reflecting upper airway collapsibility. PURPOSES: This study investigated if a new NEP test analysis on the transient expiratory DeltaV after NEP application for detection of upper airway V limitation is able to identify obstructive sleep apnea (OSA) subjects and its severity. METHODS: Thirty-seven male subjects (mean +/- SD age, 46 +/- 11 years; mean body mass index [BMI], 34 +/- 7 kg/m2) with suspected OSA and with normal spirometric values underwent nocturnal polysomnography and diurnal NEP testing at - 5 cm H2O and - 10 cm H2O in sitting and supine positions. RESULTS: deltaV (percentage of the peak V [%Vpeak]) was better correlated to apnea-hypopnea index (AHI) than the EFL measured as V, during NEP application, equal or inferior to the corresponding V during control (EFL), and expressed as percentage of control tidal volume (%Vt). AHI values were always high (> 44 events/h) in subjects with BMI > 35 kg/m2, while they were very scattered (range, 0.5 to 103.5 events/h) in subjects with BMI < 35 kg/m2. In these subjects, AHI still correlated to deltaV (%Vpeak) in both sitting and supine positions at both NEP pressures. CONCLUSIONS: OSA severity is better related to deltaV (%Vpeak) than EFL (%Vt) in subjects referred to sleep centers. DeltaV (%Vpeak) can be a marker of OSA, and it is particularly useful in nonseverely obese subjects.
Authors: Raquel P Hirata; Fabiola Schorr; Fabiane Kayamori; Henrique Takachi Moriya; Salvatore Romano; Giuseppe Insalaco; Eloisa M Gebrim; Luis Vicente Franco de Oliveira; Pedro R Genta; Geraldo Lorenzi-Filho Journal: J Clin Sleep Med Date: 2016-10-15 Impact factor: 4.062
Authors: Raquel P Hirata; Isabella C Aguiar; Sergio R Nacif; Lilian C Giannasi; Fernando S S Leitão Filho; Israel R Santos; Salvatore Romano; Newton S Faria; Paula N Nonaka; Luciana M M Sampaio; Claudia S Oliveira; Paulo T C Carvalho; Geraldo Lorenzi-Filho; Alberto Braghiroli; Adriana Salvaggio; Giuseppe Insalaco; Luis V F Oliveira Journal: BMC Pulm Med Date: 2011-12-07 Impact factor: 3.317